SkylineDx today announced the launch of the Guideline-Informed Risk Assessment Initiative, a clinical program designed to support surgeons and multidisciplinary teams in evaluating patients with T1 ...
Verastem (NASDAQ:VSTM) executives said the company’s transition to a commercial-stage business accelerated in 2025 following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results